Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor

Blood

Volumn 106, Issue 13, 2005, Pages 4241-4248

  Nishimoto, Hajime ^b   Lee, Seung Woo ^b   Hong, Hong ^b   Potter, Karen G ^b   Maeda Yamamoto, Mari ^b   Kinoshita, Tatsuya ^b   Kawakami, Yuko ^b   Mittler, Robert S ^b   Kwon, Byoung S ^b   Ware, Carl F ^b   Croft, Michael ^b   Kawakami, Toshiaki ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN RECEPTOR; MESSENGER RNA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL STIMULATION; CYTOKINE RELEASE; ENZYME ACTIVITY; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

EID: 28844480518     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-04-1358     Document Type: Article

References (39)

1. Galli SJ. Mast cells and basophils. Curr Opin Hematol. 2000;7:32-39.
2. Keegan AD, Paul WE. Multichain immune recognition receptors: similarities in structure and signaling pathways. Immunol Today. 1992;13:63-68.
3. Kinet JP. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu Rev Immunol. 1999;17:931-972.
4. Parravicini V, Gadina M, Kovarova M, et al. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol. 2002;3:741-748.
5. Turner H, Kinet JP. Signalling through the highaffinity IgE receptor FcεRI. Nature. 1999;402:B24-B30.
6. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol. 2002;2:773-786.
7. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 1992;71:1065-1068.
8. Tashiro M, Kawakami Y, Abe R, et al. Increased secretion of TNF-α by costimulation of mast cells via CD28 and FcεRI. J Immunol. 1997;158:2382-2389.
9. Croft M. Costimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol. 2003;3:609-620.
10. Kwon B, Moon CH, Kang S, Seo SK, Kwon BS. 4-1BB: still in the midst of darkness. Mol Cells. 2000;10:119-126.
11. Kwon BS, Weissman SM. cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci U S A. 1989;86:1963-1967.
12. Pollok KE, Kim YJ, Hurtado J, Zhou Z, Kim KK, Kwon BS. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells. Eur J Immunol. 1994;24:367-374.
13. - T lymphocytes by 4-1BB ligand. J Immunol. 1997;158:551-559.
14. Alderson MR, Smith CA, Tough TW, et al. Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol. 1994;24:2219-2227.
15. Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol. 1999;163:5358-5366.
16. - T cells. J Immunol. 1997;158:3081-3089.
17. DeBenedette MA, Chu NR, Pollok KE, et al. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med. 1995;181:985-992.
18. Saoulli K, Lee SY, Cannons JL, et al. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J Exp Med. 1998;187:1849-1862.
19. Cooper D, Bansal-Pakala P, Croft M. 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Eur J Immunol. 2002;32:521-529.
20. + T cell proliferation and lead to the amplifi-cation in vivo of cytotoxic T cell responses. J Exp Med. 1997;186:47-55.
21. Melero I, Shuford WW, Newby SA, et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med. 1997;3:682-685.
22. Kitaura J, Song J, Tsai M, et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcεRI. Proc Natl Acad Sci U S A. 2003;100:12911-12916.
23. Kawakami T, Inagaki N, Takei M, et al. Tyrosine phosphorylation is required for mast cell activation by FcεRI cross-linking. J Immunol. 1992;148:3513-3519.
24. Kwon BS, Hurtado JC, Lee ZH, et al. Immune responses in 4-1BB (CD137)-deficient mice. J Immunol. 2002;168:5483-5490.
25. DeBenedette MA, Wen T, Bachmann MF, et al. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol. 1999;163:4833-4841.
26. Maeda-Yamamoto M, Inagaki N, Kitaura J, et al. O-methylated catechins from tea leaves inhibit multiple protein kinases in mast cells. J Immunol. 2004;172:4486-4492.
27. cε receptor I cross-linking: an interspecies comparison. Blood. 2002;100:3861-3868.
28. Ca2+ and purified isozymes in washed permeabilized cells. J Biol Chem. 1993;268:1749-1756.
29. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature. 1989;339:64-67.
30. Kawakami Y, Kitaura J, Satterthwaite AB, et al. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J Immunol. 2000;165:1210-1219.
31. Odom S, Gomez G, Kovarova M, et al. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med. 2004;199:1491-1502.
32. 2+ following B-cell receptor activation. EMBO J. 1998;17:1973-1985.
33. lck. J Immunol. 1993;151:1255-1262.
34. Mekori YA, Metcalfe DD. Mast cell-T cell interactions. J Allergy Clin Immunol. 1999;104:517-523.
35. Henz BM, Maurer M, Lippert U, Worm M, Babina M. Mast cells as initiators of immunity and host defense. Exp Dermatol. 2001;10:1-10.
36. Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol. 1996;156:1490-1496.
37. + T lymphocytes. Eur J Immunol. 1996;26:2517-2528.
38. Sayama K, Diehn M, Matsuda K, et al. Transcriptional response of human mast cells stimulated via the FcεRI and identification of mast cells as a source of IL-11. BMC Immunol. 2002;3:5.
39. Kashiwakura J, Yokoi H, Saito H, Okayama Y. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J Immunol. 2004;173:5247-5257.